Breaking News

Sterling Pharma Expands Early Phase Development Capabilities

Investing $2.1 million in expansion project to increase chemical and analytical capabilities at its facility in Cary, NC.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sterling Pharma Solutions, a global contract development and manufacturing organization, began a $2.1 million expansion project to increase chemical and analytical capabilities at its facility in Cary, NC.   The project includes the construction of five new labs: two will be dedicated to R&D; a scale-up chemical synthesis lab; as well as Quality Control and analytical services labs. All work is due to be completed by the end of 2022, and will allow the recruitment of up to 20 additional sc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters